DED-54387-09459
3 vaccinations
7 coded responses
16 check-ins
7 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 934 / CA
- Registered
- 2021-01-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
8F5-20812-28125
Child or adolescent in my care · Male · 2022-06-24
Timeline
-
2020-12-21
Dose 1 — Pfizer-BioNTech
-
2021-01-07
Registered in v-safe
-
2021-01-07
Dose 2 — Pfizer-BioNTech
- 2021-01-07
-
2021-01-08
Survey response — days 1–6 daily, dose 2MedDRA: Feeling abnormal, Hyperaesthesia teeth, Lethargy, Rash, Rash pruritic, Toothache — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Aching pain to molars and sensitivity to cold liquids, foggy brain, minor lethargy, itchy red rash to both arm pitsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-08
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-09
Survey response — days 1–6 daily, dose 2MedDRA: Feeling abnormal, Vision blurred — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Foggy brain and some blurred visionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-09
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-10
Survey response — days 1–6 daily, dose 2MedDRA: Herpes virus infection, Pre-existing disease — Feeling: Good · Site: PainFree text: Day after vaccine, I had a herpes outbreak which had been dormant since 2004 with daily suppressive therapy.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-11
Survey response — days 1–6 daily, dose 2MedDRA: Herpes simplex, Pre-existing disease — Feeling: GoodFree text: Only side effects left is herpes outbreak that happened the day after vaccine even though I was on suppressive med and no outbreak since 2004MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-12
Survey response — days 1–6 daily, dose 2MedDRA: Herpes simplex, Pre-existing disease — Feeling: GoodFree text: Herpes outbreak post day 1 of vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-13
- 2021-01-15
- 2021-01-21
- 2021-01-28
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-04-08
-
2021-07-08
Survey response — 6 months, dose 2MedDRA: Condition aggravated, Epstein-Barr virus infection, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Flare up with EBVMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2022-01-07
Survey response — 12 months, dose 2MedDRA: COVID-19, Fatigue, Herpes simplex, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Adrenal fatigue. COVID + Aug 9, 2021 resulting in the worse HSV II outbreak I have ver had since being diagnosed with it in 2000.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-07
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-01-10
Dose 3 — Pfizer-BioNTech
- 2022-01-10
-
2022-01-11
Callback requested for01:00PM ET
-
2022-01-11
Call successfulParticipant prefers to complete VAERS report online
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech | |
| 2 | 2021-01-07 | Pfizer-BioNTech | |
| 3 | 2022-01-10 | Pfizer-BioNTech | No |
Call center
3 call center cases
1 successful · 2 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Aching pain to molars and sensitivity to cold liquids, foggy brain, minor lethargy, itchy red rash to both arm pits
Systemic reaction (other): Foggy brain and some blurred vision
Systemic reaction (other): Day after vaccine, I had a herpes outbreak which had been dormant since 2004 with daily suppressive therapy.
Systemic reaction (other): Only side effects left is herpes outbreak that happened the day after vaccine even though I was on suppressive med and no outbreak since 2004
Systemic reaction (other): Herpes outbreak post day 1 of vaccine
Release 9 — 6 months, dose 2
Symptoms: Flare up with EBV
Release 10 — 12 months, dose 2
Symptoms: Adrenal fatigue. COVID + Aug 9, 2021 resulting in the worse HSV II outbreak I have ver had since being diagnosed with it in 2000.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Condition aggravated | ✓ | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Epstein-Barr virus infection | ○ | ✓ | ○ |
| SD | Fatigue | · | · | ✓ |
| SD | Herpes simplex | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Condition aggravated | ○ | ○ | ○ |
| SRO | Feeling abnormal | ✓ | ✓ | ✓ |
| SRO | Herpes simplex | ✓ | ✓ | ✓ |
| SRO | Herpes virus infection | ✓ | ✓ | ✓ |
| SRO | Hyperaesthesia teeth | ✓ | ✓ | ✓ |
| SRO | Lethargy | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
| SRO | Rash pruritic | ✓ | ✓ | ✓ |
| SRO | Toothache | ✓ | ✓ | ✓ |
| SRO | Vision blurred | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release